Pre Conference Workshop Day

9:00 AM - 11:00 AM Quality Assurance and Regulatory Aspect of Cell and Gene Therapy Bioprocesses

  • Identify which QbD is the right approach for your therapy and examine its effectiveness when moving into the manufacturing stage
  • Decipher the different regulatory guidelines surrounding ATMP production
  • Address the different regulatory guidelines that are associated with ATMP manufacturing processes

11:00 AM - 11:30 AM Coffee Break

11:30 AM - 1:30 PM Optimised Manufacturing of Cell/Gene Therapies

  • Examine the possibilities of moving towards automated production
  • Analyse the considerations when moving to closed system processing
  • Pre-empt where pitfalls are and how to avoid them in your manufacturing process
  • Scrutinize the different elements associated with cost efficiency in production

1:30 PM - 2:30 PM Lunch

2:30 PM - 4:30 PM Commercialisation of Cell and Gene Therapies

  • Analyse the different approaches towards commercialisation of cell and gene therapies
  • Look after the different factors associated with development of therapies after stage 3 of clinical development
  • Examine datasets from autologous therapies, how to make products more viable and cost efficiency of large scale production